Qualiphar

What Qualiphar does

Qualiphar is a privately held Belgian family pharmaceutical company founded in 1937, headquartered in Bornem, Belgium (the firmographic Dubai/UAE field appears inconsistent with all other evidence: Bornem address, .be domain, Belgian pharmacy channel, Belgian consumer base). The company operates a hybrid business built on three pillars: (1) proprietary over-the-counter (OTC) medicines and consumer health products (nutritional supplements, cosmetics) sold under its own brands through Belgian pharmacies; (2) contract manufacturing (CMO) services — including R&D, production, and commercialization support — for other pharmaceutical companies; and (3) a pharmaceutical distribution arm (Farma Distributie) that provides logistics and supply chain services within Belgium. The company states it is active in more than 60 countries through its export partnerships and CMO engagements.

Its product portfolio centers on two core lines — Voorschriftvrije geneesmiddelen (non-prescription medicines) and Gezondheidsproducten (health products such as nutritional supplements and cosmetics) — with consumer brands including Shampoux Express lotion, which was voted Product of the Year 2024 in the Belgian anti-lice category. Underlying technology is conventional pharmaceutical R&D and GMP manufacturing; no proprietary technology, software platform, patents, or AI/ML systems are disclosed. The multilingual corporate website (Dutch, French, English, German, Spanish) supports both Belgian consumer reach and international B2B client acquisition.

Revenue is generated through one-time product sales (own OTC and health brands via pharmacy retail in Belgium), professional services fees from contract manufacturing engagements, and transaction-based fees from pharmaceutical distribution. The go-to-market is sales-led and channel-driven: B2B via direct relationships with export partners and CMO clients across 60+ countries, and B2C via the Belgian pharmacy network. No public pricing models, customer counts, revenue figures, or financial disclosures are available; the company is small (11-50 employees), independent, and family-owned with no disclosed parent, institutional investors, or funding rounds.

Name

Qualiphar

Legal name

Qualiphar

Website

https://qualiphar.com

Company type

Private

Founded year

1937

Operating status

Operating

Headcount range

11–50 employees

Short description

Qualiphar is a Belgian family-owned pharmaceutical company founded in 1937 that develops, manufactures, and distributes OTC medicines, health products, and cosmetics in Belgium while offering contract manufacturing and pharmaceutical distribution services to clients in more than 60 countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Dubai

HQ country

United Arab Emirates

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Product Sales - OTC Medicines: Sale of over-the-counter (prescription-free) medicines directly to Belgian consumers and through pharmacy channels.
2. Product Sales - Health Products: Commercialization of health products including nutritional supplements, cosmetics, and other wellness products through pharmacy and retail channels.
3. Contract Manufacturing Services (CMO): Custom manufacturing and production services offered to third-party pharmaceutical companies in Belgium and 60+ export countries. Qualiphar provides R&D, production, and commercialization capabilities to other businesses.
4. Pharmaceutical Distribution: Distribution services for pharmaceutical products in Belgium, offering logistics and supply chain services to other companies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Qualiphar is a Belgian family company that develops, manufactures, and commercializes over-the-counter (OTC) medicines, nutritional supplements, cosmetics, and other health products. In addition to its own brand portfolio, the company offers contract manufacturing (CMO) services and pharmaceutical distribution to third-party companies in Belgium and more than 60 export countries.

Product overview

Qualiphar offers a portfolio of non-prescription medicines (OTC) and health products including nutritional supplements and cosmetics. The company specializes in research and development, production, and commercialization of self-care medicines and health products for family well-being. The core product lines include Voorschriftvrije geneesmiddelen (OTC medicines) and Gezondheidsproducten (health products such as nutritional supplements and cosmetics), with brands like Shampoux Express lotion.

Differentiator

Problem solved

Functional benefit

Products and services

• Voorschriftvrije geneesmiddelen (OTC medicines) Over-the-counter (OTC) non-prescription medicines developed and produced by Qualiphar for family health and well-being, sold through Belgian pharmacies.
• Gezondheidsproducten (Health products) Health products including nutritional supplements, cosmetics, and other wellness products designed to address specific consumer health needs or enhance quality of life.
• Shampoux Express lotion Anti-lice treatment lotion produced by Qualiphar; awarded Product of the Year 2024 in Belgium in the anti-lice category by consumer vote.
• Contract Manufacturing (CMO) Custom pharmaceutical manufacturing, R&D, and commercialization services offered to large and small pharmaceutical companies in Belgium and more than 60 export countries.
• Pharmaceutical Distribution (Farma Distributie) Pharmaceutical wholesale and distribution services provided to other companies within Belgium.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Perrigo Company: Global leader in OTC, self-care, and consumer healthcare products and acquirer of Omega Pharma; comparable as a vertically integrated store-brand and OTC manufacturer competing for the same shelf space and pharmacy distribution.
• Bayer Consumer Health: Global OTC and self-care division of one of the largest life sciences groups; comparable as an OTC/CHC brand and manufacturer present on the same Belgian pharmacy shelves as Qualiphar.
• STADA Arzneimittel: Major European generics and consumer healthcare group with extensive OTC, supplement, and contract manufacturing capabilities across multiple European countries; broader than Qualiphar but operates in identical product categories and channels.
• Teva Pharmaceutical Industries: Global generics leader with a substantial OTC and consumer healthcare arm in Europe; competes with Qualiphar in OTC and supplements at retail scale, though from a vastly larger M&A-driven platform.

Regional players

• Phoenix Group: European pharmaceutical wholesaler and distribution group with strong Benelux and German operations; comparable through Qualiphar's Farma Distributie distribution business, although Phoenix operates at significantly larger scale and broader European scope.

Direct peers

• Omega Pharma (now part of Perrigo): Belgian OTC and consumer healthcare company historically family-owned; closest direct comparison as a Belgian-rooted OTC/CHC manufacturer and brand owner with broad pharmacy distribution across Europe.
• Vemedia Pharma: Independent Benelux consumer healthcare/OTC manufacturer with branded OTC medicines, supplements, and medical devices sold mainly through pharmacy and drugstore channels; comparable model to Qualiphar's brand portfolio with Belgian/Dutch regional overlap.
• Will-Pharma: Belgian pharmaceutical and consumer health company offering OTC medicines, supplements, and medical devices through Belgian pharmacies; small Belgian family-style analogue with overlapping domestic channel.
• Cooper Consumer Health: European independent OTC and consumer healthcare company formed from combinations of legacy family-owned pharma brands across multiple countries; closest direct structural analogue to Qualiphar in terms of private, multi-country OTC portfolio with manufacturing.

Emerging players

• HRA Pharma: European consumer healthcare company focused on switches, OTC, and women's health; comparable as a mid-sized, focused consumer-health player with a portfolio-led approach and retail-pharmacy distribution.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Qualiphar
• LinkedInlinkedin.com/company/qualiphar-nv
• Instagraminstagram.com/qualiphar_nv

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qualiphar